manibiotech,
It’s worse than that for you all because you can’t come up with a single CDMO that went on to produce a game changing platform technology capable of treating all solid tumor cancers. An example like that would form some sort of defense for your assertion that NWBO should have taken on the full burden of CDMO development while spending on research and development of their initially unproven and widely unsupported platform technology but you have no example. There are plenty of examples of failed trials by big pharma and failed biotechs because the did not have the wear withal to recover from trial failure or from over extending their resources.
While you all conger up recipes for disaster and pretend they are recipes for success NWBO moves ahead, leading the pack while chronicling the pathway to real success and benefit for cancer patients.
While you attempt to create dissensions by appealing to self centered short sightedness you also ignore the fact that somehow this board’s success at calling the shots with regard to validation of the science and upward price trend from the double bottom in March 2020 until now should be disregarded. Only those unwilling to do the least bit of due diligence would possibly fall for what you are saying. The rest of us watch those howling at the moon with their swan song; ). Best wishes.